These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27973622)
1. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and Identification of Gaps. Gorst SL; Gargon E; Clarke M; Smith V; Williamson PR PLoS One; 2016; 11(12):e0168403. PubMed ID: 27973622 [TBL] [Abstract][Full Text] [Related]
2. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey. Gorst SL; Gargon E; Clarke M; Blazeby JM; Altman DG; Williamson PR PLoS One; 2016; 11(1):e0146444. PubMed ID: 26785121 [TBL] [Abstract][Full Text] [Related]
3. Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries. Davis K; Gorst SL; Harman N; Smith V; Gargon E; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR PLoS One; 2018; 13(2):e0190695. PubMed ID: 29438429 [TBL] [Abstract][Full Text] [Related]
4. Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for research. Gargon E; Gorst SL; Matvienko-Sikar K; Williamson PR PLoS One; 2021; 16(1):e0244878. PubMed ID: 33434219 [TBL] [Abstract][Full Text] [Related]
5. Choosing important health outcomes for comparative effectiveness research: a systematic review. Gargon E; Gurung B; Medley N; Altman DG; Blazeby JM; Clarke M; Williamson PR PLoS One; 2014; 9(6):e99111. PubMed ID: 24932522 [TBL] [Abstract][Full Text] [Related]
6. Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic review. Dodd S; Gorst SL; Young A; Lucas SW; Williamson PR J Clin Epidemiol; 2023 Jun; 158():127-133. PubMed ID: 37054902 [TBL] [Abstract][Full Text] [Related]
7. Choosing important health outcomes for comparative effectiveness research: 5th annual update to a systematic review of core outcome sets for research. Gargon E; Gorst SL; Williamson PR PLoS One; 2019; 14(12):e0225980. PubMed ID: 31830081 [TBL] [Abstract][Full Text] [Related]
8. Choosing important health outcomes for comparative effectiveness research: 4th annual update to a systematic review of core outcome sets for research. Gargon E; Gorst SL; Harman NL; Smith V; Matvienko-Sikar K; Williamson PR PLoS One; 2018; 13(12):e0209869. PubMed ID: 30592741 [TBL] [Abstract][Full Text] [Related]
9. Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys. Biggane AM; Brading L; Ravaud P; Young B; Williamson PR Trials; 2018 Feb; 19(1):113. PubMed ID: 29454368 [TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of a research funder's recommendation to consider core outcome sets. Hughes KL; Kirkham JJ; Clarke M; Williamson PR PLoS One; 2019; 14(9):e0222418. PubMed ID: 31518375 [TBL] [Abstract][Full Text] [Related]
11. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol. Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910 [TBL] [Abstract][Full Text] [Related]
13. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study. Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216 [TBL] [Abstract][Full Text] [Related]
14. Assessment highlights need for improvement in standards of development of core outcome sets for rare genetic diseases. Ciucă A; Banka S; Newman WG; Moldovan R; Kirkham JJ J Clin Epidemiol; 2023 Sep; 161():84-93. PubMed ID: 37423316 [TBL] [Abstract][Full Text] [Related]
15. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome. Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A; Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170 [TBL] [Abstract][Full Text] [Related]
16. Core Outcome Set-STAndards for Development: The COS-STAD recommendations. Kirkham JJ; Davis K; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR PLoS Med; 2017 Nov; 14(11):e1002447. PubMed ID: 29145404 [TBL] [Abstract][Full Text] [Related]
17. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207 [TBL] [Abstract][Full Text] [Related]
18. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment. Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK; Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595 [TBL] [Abstract][Full Text] [Related]
19. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions. Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366 [TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]